Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (2)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (2)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (2)
Articles (1)

Topics

Eye Anatomy and Disorders (1)
Pharmacology (1)
Translational Research (1)
Vitreous Disorders (1)

Tags

aflibercept (1)
anti-vascular endothelial growth factor therapy (1)
brolucizumab (1)
half-life (1)
molar tooth (1)
treatment outcome (1)
vascular endothelial growth factor a (1)
vitreous body (1)

Specify Date Range

From: To: Apply

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8 mg and 2 mg and association with durability of effect

Peter K Kaiser; Kenneth C Turner; Sébastien Bihorel; Joannellyn Chiu; Lutz Harnisch; Jason Chittenden; Thomas Eissing; Joachim Höchel; Torsten Zimmermann; Thomas DiCioccio

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3154.

Articles April 2021

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

PDF

Thomas Eissing; Michael W. Stewart; Cynthia X. Qian; Kay D. Rittenhouse
TAGS: aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, vascular endothelial growth factor a, treatment outcome, vitreous body, half-life, molar tooth
Trans. Vis. Sci. Tech.. 2021; 10(4):9. https://doi.org/10.1167/tvst.10.4.9

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Pharmacokinetic Simulations of Intravitreal Aflibercept and Brolucizumab to Explore Results from Clinical Trials

Cynthia Qian; Kay D Rittenhouse; Thomas Eissing; Samia Ezzine; Todd A Katz; Jean Daniel Arbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4206.

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept